Figure 4 from Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinica... par Natalie C. Fisher (15046025)

Sujets:

Table 2_AI literacy and competency in nursing education: preparing students and faculty members for an AI-enabled future-a systematic review and meta-analysis.docx par Majeda M. El-Banna (21480251)

Sujets: “…Foetal Development and Medicine…”

Figure 1 from Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinica... par Natalie C. Fisher (15046025)

Sujets:

Supplementary Table 2 from Somatic Exonic Deletions in <i>RUNX1</i> Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia par Anna Eriksson (15352461)

Sujets:

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma... par Kazuhito Suzuki (22688384)

Sujets: “…Medicine…”

Supplementary Table1 from Somatic Exonic Deletions in <i>RUNX1</i> Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia par Anna Eriksson (15352461)

Sujets:

Elamipretide: First Approval par Matt Shirley (7340599)

Sujets: “…Medicine…”

Supplementary Figure S2 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplifica... par Chong Kin Liam (15331321)

Sujets:

Supplementary Figure S3 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplifica... par Chong Kin Liam (15331321)

Sujets:

Supplementary Table S2 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma par Naveen S. Vasudev (15057037)

Sujets:

Supplementary Figure S4 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplifica... par Chong Kin Liam (15331321)

Sujets:

Supplementary Table S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma par Naveen S. Vasudev (15057037)

Sujets:

Validation and normative data of the Italian Face-Name Association Test (ItFNAT): A tool for cross-modal memory assessment par Valerio Manippa (5997128)

Sujets: “…Medicine…”

Supplementary Figure S1 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplifica... par Chong Kin Liam (15331321)

Sujets:

Supplementary Figure S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial par Tobias Kessler (17079209)

Sujets:

“All the magic happens in between therapy sessions”: Speech-language pathologists’ experiences of collaborative approaches with families par Jessica Hassett (22676729)

Sujets: “…Medicine…”

Additional file 1 of Timing of mortality during development alters the evolution of aging par Peter Lenart (22678465)

Sujets: “…Medicine…”

Supplementary Figure S3 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial par Tobias Kessler (17079209)

Sujets:

Genome-wide methylation changes upon Caco-2 cells exposure to undigested and digested titanium dioxide nanoparticles par Célia Ventura (8440917)

Sujets: “…Medicine…”

Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial par Tobias Kessler (17079209)

Sujets: